Cabaletta Bio Inc

Cabaletta Bio Inc

Updated August 2022.


Employees say this is a great place to work

Company Overview

About The Company

Cabaletta Bio is focused on the discovery and development of T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T cell products to transform the lives of patients with autoimmune diseases by aiming to deliver deep and durable – potentially curative – responses.


57 U.S.-based Employees


Biotechnology & Pharmaceuticals

Employee Demographics


Company Culture at Cabaletta Bio Inc

The employee experience below at Cabaletta Bio Inc, compared to a typical company.

Learn More

100% of employees at Cabaletta Bio Inc say it is a great place to work compared to 57% of employees at a typical U.S.-based company.

  • Cabaletta Bio Inc
  • 100%
  • Typical Company
  • 57%
Management keeps me informed about important issues and changes.
Management is approachable, easy to talk with.
Management is competent at running the business.
Management is honest and ethical in its business practices.
Our executives fully embody the best characteristics of our company.

Why Work at Cabaletta Bio Inc?

See what employees say about what makes Cabaletta Bio Inc a great workplace. These words are drawn from employee comments on the Trust Index™ survey.

Best Workplaces Lists

Great Place To Work® is proud to recognize Cabaletta Bio Inc

Don't See Your Company Listed?

Nominate your company today to join Certification Nation